JP2020514299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514299A5 JP2020514299A5 JP2019536976A JP2019536976A JP2020514299A5 JP 2020514299 A5 JP2020514299 A5 JP 2020514299A5 JP 2019536976 A JP2019536976 A JP 2019536976A JP 2019536976 A JP2019536976 A JP 2019536976A JP 2020514299 A5 JP2020514299 A5 JP 2020514299A5
- Authority
- JP
- Japan
- Prior art keywords
- chemical formula
- solvate
- hydrate
- structure represented
- following chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)C*C(*)(*)SSC*(*)C*CN(*)CIC(CON)CON Chemical compound CC(C)C*C(*)(*)SSC*(*)C*CN(*)CIC(CON)CON 0.000 description 3
- ANZUADGNOKSXOB-UHFFFAOYSA-N CCOc1ccc(C(CC2)C(CC3)C(CC4)C2(C)C4OCCCOC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c3c1 Chemical compound CCOc1ccc(C(CC2)C(CC3)C(CC4)C2(C)C4OCCCOC(C(F)(F)F)(C(F)(F)F)C(F)(F)F)c3c1 ANZUADGNOKSXOB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762443822P | 2017-01-09 | 2017-01-09 | |
| US62/443,822 | 2017-01-09 | ||
| PCT/IL2018/050031 WO2018127927A1 (en) | 2017-01-09 | 2018-01-09 | Compounds and methods for trans-membrane delivery of molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020514299A JP2020514299A (ja) | 2020-05-21 |
| JP2020514299A5 true JP2020514299A5 (enExample) | 2021-02-18 |
| JP7348064B2 JP7348064B2 (ja) | 2023-09-20 |
Family
ID=62789169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536976A Active JP7348064B2 (ja) | 2017-01-09 | 2018-01-09 | 分子を経膜送達するための化合物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11230710B2 (enExample) |
| EP (1) | EP3565603B1 (enExample) |
| JP (1) | JP7348064B2 (enExample) |
| KR (1) | KR20190104392A (enExample) |
| CN (1) | CN110402152B (enExample) |
| AU (1) | AU2018205898B2 (enExample) |
| CA (1) | CA3049640A1 (enExample) |
| EA (1) | EA201991661A1 (enExample) |
| IL (1) | IL267919B2 (enExample) |
| WO (1) | WO2018127927A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11318206B2 (en) | 2014-03-28 | 2022-05-03 | Aposense Ltd | Compounds and methods for trans-membrane delivery of molecules |
| CN110402152B (zh) | 2017-01-09 | 2024-03-19 | 艾博森斯有限公司 | 用于分子的跨膜递送的化合物和方法 |
| US10195286B2 (en) * | 2017-07-04 | 2019-02-05 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| EP3735276A4 (en) * | 2018-01-01 | 2021-10-13 | Aposense Ltd. | COMPOUNDS AND METHODS FOR THE TRANSMEMBRANARY ADMINISTRATION OF MOLECULES |
| WO2020044349A1 (en) * | 2018-08-30 | 2020-03-05 | Aposense Ltd. | Compounds, cojugates and compositions for use in the methods for trans-membrane delivery of molecules |
| JPWO2023022055A1 (enExample) * | 2021-08-17 | 2023-02-23 | ||
| KR20260110145A (ko) | 2023-10-30 | 2026-07-14 | 올페라 코퍼레이션 | 후각 전달 스캐폴드 및 이를 제조하고 사용하는 방법 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU736301B2 (en) | 1996-05-01 | 2001-07-26 | Imarx Therapeutics, Inc. | Methods for delivering compounds into a cell |
| US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
| WO1998050041A1 (en) | 1997-05-06 | 1998-11-12 | Imarx Pharmaceutical Corp. | Novel prodrugs comprising fluorinated amphiphiles |
| FR2846969A1 (fr) | 2002-11-08 | 2004-05-14 | Salles Jean Pierre | Nouveaux vecteurs moleculaires amphiphiles fluorocarbones a usage biomedical et medical |
| SE527131C2 (sv) | 2004-02-13 | 2005-12-27 | Innoventus Project Ab | Steroider för cancerbehandling |
| JP2008505884A (ja) | 2004-07-08 | 2008-02-28 | エヌエスティー・ニューロサバイバル・テクノロジーズ・リミテッド | 疾患を検出する方法および化合物 |
| AU2005281359A1 (en) | 2004-08-26 | 2006-03-16 | Apparao Satyam | Prodrugs and codrugs containing novel bio-cleavable disulfide linkers |
| EA200700741A1 (ru) | 2004-10-01 | 2007-08-31 | Прометик Байосайенсиз Инк. | Жирные спирты со средней длиной цепи как стимуляторы гематопоэза |
| MX2007010113A (es) | 2005-02-18 | 2007-12-07 | Angiochem Inc | Polipeptidos de aprotinina para transportar un compuesto a traves de la barrera hematoencefalica. |
| EP2081949B1 (en) | 2006-09-22 | 2014-12-10 | GE Healthcare Dharmacon, Inc. | Tripartite oligonucleotide complexes and methods for gene silencing by rna interference |
| EP2229186A2 (en) | 2007-12-04 | 2010-09-22 | Alnylam Pharmaceuticals Inc. | Carbohydrate conjugates as delivery agents for oligonucleotides |
| MX2010012238A (es) | 2008-05-13 | 2011-04-11 | Univ Washington | Copolimeros dibloque y sus complejos con polinucleotidos destinados a introducirlos en celulas. |
| WO2009155335A2 (en) | 2008-06-19 | 2009-12-23 | University Of Maryland, Baltimore | Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization |
| EP2342340A1 (en) | 2008-09-22 | 2011-07-13 | Rxi Pharmaceuticals Corporation | Rna interference in skin indications |
| WO2012018729A1 (en) | 2010-08-03 | 2012-02-09 | Berry And Associates, Inc. | Phosphoramidite derivatives of folic acid |
| GB201122458D0 (en) | 2011-12-30 | 2012-02-08 | Univ Wageningen | Modified cascade ribonucleoproteins and uses thereof |
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| WO2013181440A1 (en) | 2012-05-30 | 2013-12-05 | Baylor College Of Medicine | Supercoiled minivectors as a tool for dna repair, alteration and replacement |
| EA201590622A1 (ru) * | 2012-10-16 | 2015-10-30 | Эндосайт, Инк. | Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения |
| US20160002159A1 (en) | 2013-02-13 | 2016-01-07 | Neal ZONDLO | Perfluoro-tert-butyl hydroxyproline |
| CN110003066B (zh) | 2013-11-18 | 2021-09-03 | 阿克丘勒斯治疗公司 | 用于rna递送的可电离的阳离子脂质 |
| US9889202B2 (en) | 2014-03-28 | 2018-02-13 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| US9993563B2 (en) | 2014-03-28 | 2018-06-12 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| EP3125946B1 (en) | 2014-03-28 | 2022-12-07 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
| US20160016855A1 (en) * | 2014-07-21 | 2016-01-21 | Benxin Wu | Fabrication of carbon nanotube-nonoxide structural ceramic nanocomposites through laser sintering |
| CN110402152B (zh) | 2017-01-09 | 2024-03-19 | 艾博森斯有限公司 | 用于分子的跨膜递送的化合物和方法 |
| US10195286B2 (en) | 2017-07-04 | 2019-02-05 | Aposense Ltd. | Compounds and methods for trans-membrane delivery of molecules |
-
2018
- 2018-01-09 CN CN201880017053.0A patent/CN110402152B/zh active Active
- 2018-01-09 KR KR1020197023505A patent/KR20190104392A/ko not_active Withdrawn
- 2018-01-09 JP JP2019536976A patent/JP7348064B2/ja active Active
- 2018-01-09 CA CA3049640A patent/CA3049640A1/en active Pending
- 2018-01-09 AU AU2018205898A patent/AU2018205898B2/en active Active
- 2018-01-09 EA EA201991661A patent/EA201991661A1/ru unknown
- 2018-01-09 IL IL267919A patent/IL267919B2/en unknown
- 2018-01-09 US US16/476,557 patent/US11230710B2/en active Active
- 2018-01-09 WO PCT/IL2018/050031 patent/WO2018127927A1/en not_active Ceased
- 2018-01-09 EP EP18736287.6A patent/EP3565603B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7075669B2 (ja) | 核酸送達用カチオン性脂質及びその調製物 | |
| JP2022505234A5 (enExample) | ||
| JP2017061563A5 (enExample) | ||
| Mével et al. | DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA | |
| ES2987915T3 (es) | Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos | |
| CN114945556B (zh) | 用于核酸转染的类脂质及其用途 | |
| BR112013016761B1 (pt) | Uso de um composto, composto e composição farmacêutica | |
| JP2012518029A5 (enExample) | ||
| JP2014534220A5 (enExample) | ||
| JP2020525502A5 (enExample) | ||
| RU2016142510A (ru) | Соединения и способы для транс-мембранной доставки молекул | |
| JP2003511045A (ja) | Ｒｎａ結合化合物の同定方法 | |
| AU2018370019B2 (en) | Stable compositions of pegylated carfilzomib compounds | |
| AU2007303205A1 (en) | Lipid containing formulations | |
| JP2021502346A5 (enExample) | ||
| JP2016535058A5 (enExample) | ||
| JPWO2021049504A5 (enExample) | ||
| CN117529490A (zh) | 用于将药物递送至肝细胞的环状肽-N-乙酰半乳糖胺（GalNAc）缀合物 | |
| JP2013537404A5 (enExample) | ||
| JP2018527360A5 (enExample) | ||
| US20130079383A1 (en) | Lipid Compounds Targeting VLA-4 | |
| CN117964514A (zh) | 可电离脂质化合物及其制备方法和应用 | |
| WO2026092677A1 (zh) | 一种新型可离子化脂质及其制备方法与应用 | |
| JP2020514383A (ja) | 修飾オリゴヌクレオチドおよびその治療上の使用 | |
| WO2011154580A1 (es) | Nuevos inhibidores de cxcr4 como agentes anti-vih |